Organon & Co. (OGN)
6.56
-0.15
(-2.24%)
USD |
NYSE |
Mar 06, 16:00
6.60
+0.04
(+0.61%)
Pre-Market: 20:00
Organon Total Assets (Quarterly) : 12.87B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 136.87B |
| Amphastar Pharmaceuticals, Inc. | 1.678B |
| Plus Therapeutics, Inc. | 18.67M |
| Geron Corp. | 571.08M |
| Vertex Pharmaceuticals, Inc. | 26.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.12B |
| Shareholders Equity (Quarterly) | 752.00M |
| Debt to Equity Ratio | 11.70 |
| Current Ratio | 1.821 |
| Net Debt Paydown Yield | -0.55% |